Show simple item record

dc.contributor.authorJames, Jonathan
dc.date.accessioned2023-03-13T11:09:58Z
dc.date.available2023-03-13T11:09:58Z
dc.date.issued2021
dc.identifier.citationChen, Y., James, J.J., Michalopoulou, E., Darker, I.T. and Jenkins, J. (2021) 'The relationship between missed breast cancers on mammography in a test-set based assessment scheme and real-life performance in a National Breast Screening Programme', European Journal of Radiology, 142, pp. 109881. doi: 10.1016/j.ejrad.2021.109881.en_US
dc.identifier.issn1872-7727
dc.identifier.urihttp://hdl.handle.net/20.500.12904/16390
dc.description.abstractPURPOSE: This retrospective study determined whether a test-set based assessment scheme (PERFORMS) used in a national breast screening programme could be used to predict real-life performance by investigating if the number of cancers missed by mammography readers in real-life related to the number of cancers missed in the PERFORMS test-set and whether real-life reading volumes affected performance., METHOD: Data was obtained from consenting readers in the screening programme in England (NHSBSP) where double reading is standard. The rate of cancers missed by individual first readers but correctly identified by second readers was compared with the number of cancers missed in the PERFORMS test-set over a 3-year period. NHSBSP readers are required to interpret at least 1500 cases per year as a first reader, so results were compared between readers who exceeded this target and those that did not. Parametric and non-parametric correlations were calculated., RESULTS: Amongst the 536 readers, there was a highly significant positive correlation between the real-life and PERFORMS test-set missed cancer metrics (Pearson Correlation = 0.228, n = 536, p < .0001, Spearman's rho = 0.265, n = 536, p < .0001). There was no significant difference in rates of missed cancers between the 452 readers who exceeded the 1500 first read per year target and those who did not (t(94.2) = -1.87, p = .0643, r = 0.19)., CONCLUSIONS: The use of a test-set based assessment scheme accurately reflects real-life mammography reading performance, indicating that it can be a useful tool in identifying poor reader performance. Crown Copyright © 2021. Published by Elsevier B.V. All rights reserved.
dc.description.urihttps://doi.org/10.1016/j.ejrad.2021.109881en_US
dc.language.isoenen_US
dc.publisherElsevier Ltd.en_US
dc.subjectAssessmenten_US
dc.subjectBreast canceren_US
dc.subjectMammographyen_US
dc.titleThe relationship between missed breast cancers on mammography in a test-set based assessment scheme and real-life performance in a national breast screening programmeen_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionVoRen_US
rioxxterms.versionofrecord10.1016/j.ejrad.2021.109881en_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.dateFCD2023-03-13T11:09:58Z
refterms.versionFCDVoR
refterms.panelUnspecifieden_US
html.description.abstractPURPOSE: This retrospective study determined whether a test-set based assessment scheme (PERFORMS) used in a national breast screening programme could be used to predict real-life performance by investigating if the number of cancers missed by mammography readers in real-life related to the number of cancers missed in the PERFORMS test-set and whether real-life reading volumes affected performance., METHOD: Data was obtained from consenting readers in the screening programme in England (NHSBSP) where double reading is standard. The rate of cancers missed by individual first readers but correctly identified by second readers was compared with the number of cancers missed in the PERFORMS test-set over a 3-year period. NHSBSP readers are required to interpret at least 1500 cases per year as a first reader, so results were compared between readers who exceeded this target and those that did not. Parametric and non-parametric correlations were calculated., RESULTS: Amongst the 536 readers, there was a highly significant positive correlation between the real-life and PERFORMS test-set missed cancer metrics (Pearson Correlation = 0.228, n = 536, p < .0001, Spearman's rho = 0.265, n = 536, p < .0001). There was no significant difference in rates of missed cancers between the 452 readers who exceeded the 1500 first read per year target and those who did not (t(94.2) = -1.87, p = .0643, r = 0.19)., CONCLUSIONS: The use of a test-set based assessment scheme accurately reflects real-life mammography reading performance, indicating that it can be a useful tool in identifying poor reader performance. Crown Copyright © 2021. Published by Elsevier B.V. All rights reserved.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


This item appears in the following Collection(s)

Show simple item record